Epitalon Research Peptide

Telomeres are the protective caps on the ends of chromosomes, and in most adult cells they shorten a little with every division. Telomerase is the enzyme that can rebuild them, but in ordinary somatic cells its catalytic subunit, hTERT, is largely switched off. That is why one result from Khavinson’s group attracted so much attention: adding Epitalon to cultures of telomerase-negative human fetal fibroblasts was reported to induce expression of the catalytic subunit, measurable telomerase activity and telomere elongation (Learn more).

Two decades later, an independent team at Brunel University London revisited the question with modern quantitative methods. Working with normal epithelial cells and fibroblasts alongside two breast cancer cell lines (21NT and BT474), they reported concentration-dependent telomere lengthening in the normal cells, driven by higher hTERT expression and telomerase activity. The cancer lines also showed lengthening, but mainly through a separate route called ALT (alternative lengthening of telomeres), with only a minor ALT increase in normal cells (Learn more). That split between normal and cancer cells is a key open question for telomere studies.

Epitalon began as a question about the pineal gland. Khavinson’s team had been working with epithalamin, a polypeptide extract of bovine pineal tissue, and Epitalon was synthesised to match the amino-acid composition of that extract. According to a recent review, it was later identified in the pineal polypeptide complex itself (Learn more).

The pineal gland is the body’s main source of melatonin, the hormone that tracks the light–dark cycle, so melatonin has been a natural focus. In female rhesus monkeys, Epitalon was reported to stimulate evening melatonin production in older animals and to normalise the daily rhythm of cortisol (Learn more). The same review lists a direct influence on melatonin synthesis among the compound’s documented effects, alongside changes in enzyme activity and interleukin-2 signalling. For researchers interested in how ageing interacts with circadian timing, this pineal–melatonin connection is what sets Epitalon apart from most other peptides in ageing research.

Epitalon is one of relatively few short peptides to have been followed across the whole lifespan of laboratory animals. In a study by Anisimov, Khavinson and colleagues in Biogerontology, female Swiss-derived SHR mice were followed from young adulthood until natural death. Epitalon did not change food intake, body weight or mean lifespan. It did slow the age-related decline in oestrous cycling, reduce chromosome aberrations by 17.1%, increase maximum lifespan by 12.3% and coincide with a six-fold lower incidence of leukaemia compared with controls (Learn more).

Other work from the same research circle has reported fewer chromosome aberrations in senescence-accelerated mice and fewer spontaneous tumours in C3H/He mice. Tracking several markers over a lifetime, rather than one end point, is why these studies are so often cited.

Khavinson’s group describes Epitalon as a “peptide bioregulator”: a short peptide proposed to act inside the cell nucleus rather than at a surface receptor. Their systematic review argues that peptides of two to seven amino acids can enter the nucleus and interact with histone proteins and DNA, including sequences in gene promoters.

In human gingival mesenchymal stem cells, Epitalon was reported to increase production of the neuronal differentiation markers Nestin, GAP43, beta-tubulin III and doublecortin, with mRNA for these genes rising 1.6 to 1.8-fold (Learn more). Molecular modelling in the same paper suggested AEDG binds preferentially to the linker histones H1/3 and H1/6 at sites that contact DNA, offering one possible epigenetic route. Earlier work on cultured lymphocytes from elderly donors reported loosening of tightly packed heterochromatin. The same bioregulator idea runs through research on Pinealon, a three-amino-acid peptide from the same group, which makes the two a natural pair for comparative studies.

Epitalon’s research footprint now reaches well beyond telomeres. Several studies have reported increased activity of antioxidant enzymes such as superoxide dismutase and glutathione peroxidase in experimental models. A recent study used human retinal pigment epithelial cells (ARPE-19) exposed to high glucose, a laboratory model of diabetic retinopathy. High glucose slowed wound closure, raised reactive oxygen species and pushed the cells towards a scar-like, fibrotic state; Epitalon restored the delayed wound healing by countering that shift (Learn more). The retina is a recurring theme, as Khavinson’s group has long linked AEDG to retinal as well as pineal tissue.

For laboratories building a broader ageing programme, Epitalon pairs well with NAD+, which approaches ageing through cellular energy metabolism rather than telomeres and pineal signalling. Our Epitalon vs NAD+ article compares the two side by side.